Skip to content

Opening book details…

About this Medicine article

Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report. by Sorensen, J M; Vena, D A; Fallavollita, A; Chun, H G; Cheson, B D is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Sorensen, J M; Vena, D A; Fallavollita, A; Chun, H G; Cheson, B D
Publisher
American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)
Published
1997
Language
EN
Field
Medicine (Health Sciences)

More by Sorensen, J M; Vena, D A; Fallavollita, A; Chun, H G; Cheson, B D

Browse all works by Sorensen, J M; Vena, D A; Fallavollita, A; Chun, H G; Cheson, B D